Getting your Trinity Audio player ready...
|
Intro-Act has set a price target of $3.30 for Peraso Inc. (NASDAQ: PRSO) following the company’s Q3 2024 earnings report. The firm maintains a buy rating, emphasizing Peraso’s strong financial performance and promising growth trajectory.
On November 14, Peraso announced its third fiscal quarter results, highlighting a positive outlook. Revenue aligned with management’s expectations, while operational efficiency improved by 20% year-over-year. Notably, operating expenses declined by 34% year-over-year, reflecting the success of the company’s cost-reduction initiatives.
Peraso’s products continued to gain global traction, with increased adoption in Africa, South Korea, North America, and Europe. The company’s customer diversification strategy showed results, converting nine design engagements into new client introductions. Furthermore, 95% of Peraso’s clientele are well-established WISPs (wireless internet service providers), underscoring the acceptance of its technology within the industry. Read Entire Report.
The company also achieved significant milestones in fixed wireless access (FWA) for military communications and transportation. Its DUNE platform secured a $1.4 million follow-on order from a South African WISP, further demonstrating demand for its solutions.
Looking ahead, Peraso projects double-digit year-over-year revenue growth in the second half of 2024, outpacing the first half. The Intro-Act report highlighted Peraso’s robust sales pipeline, which could lead to major order wins and reinforce its leadership in the mmWave technology sector.
Several innovative Nasdaq-listed companies in additional to Peraso Inc. (NASDAQ: PRSO), are capturing the attention of investors this week with transformative initiatives that reflect their growth potential and industry impact, spanning technology, energy, healthcare and biotech.
- Quantum Computing Inc. (NASDAQ: QUBT): Secured $40M through a direct offering to fund debt repayment, working capital, and corporate growth.
- Aclaris Therapeutics Inc. (NASDAQ: ACRS): Entered a $40M global licensing deal for two cutting-edge immunology assets, $900M potential milestone payments.
- Interactive Strength Inc. (NASDAQ: TRNR): Expands CLMBR fitness equipment in Saudi Arabia through installations at Armah Sports Group’s B_FIT locations.
- Alternus Clean Energy Inc. (NASDAQ: ALCE): Improved shareholder equity by $4M and eliminated $30M in debt through the sale of SPVs to its majority shareholder.
From groundbreaking technologies to strategic partnerships and financial advancements, these companies are driving innovation and reshaping their respective industries. They are essential additions to any watchlist for investors seeking dynamic opportunities.